Stress-Induced Hyperthermia vs True Fever
Clinical Implications and Diagnostic Considerations
- Chronic stress can suppress protective immune responses and dysregulate Type 1/Type 2 cytokine balance, leading to low-grade chronic inflammation and "sickness behavior" symptoms in patients, as noted by the Pediatrics society 1
- True fever requires evaluation for infectious or inflammatory causes and may warrant biomarker testing to distinguish infection from other inflammatory processes, according to the Society of Critical Care Medicine 2, 3, 4, 5
- Drug-induced fever should be considered in patients with recent medication changes, with a mean lag time of 21 days and a median of 8 days, representing a distinct entity from both stress-induced hyperthermia and infection-induced fever, as reported by the Society of Critical Care Medicine 2, 3, 5
Immunological Overlap and Consequences
- Immunogenic cell death from cellular stress can activate adaptive immunity through danger signals and cytokine release, as described by the Journal for ImmunoTherapy of Cancer society 6
- COVID-19 and similar viral infections can produce exaggerated inflammatory responses, leading to true fever and potentially severe outcomes, with a 10-15 point increase on an immunity scale, as noted by the Autoimmunity Reviews society 7
- Older adults with pre-existing subclinical inflammation may have baseline immune activation that, when combined with additional stressors, more readily progresses to pathological inflammatory states, according to the Autoimmunity Reviews society 7
Fever Mechanism and Regulation
Definition and Distinction
- The American College of Critical Care Medicine distinguishes fever from hyperthermia, noting that fever involves a regulated upward shift in the hypothalamic set-point with intact thermoregulatory mechanisms, whereas hyperthermia represents uncontrolled temperature elevation where thermoregulatory mechanisms are overwhelmed or dysfunctional 8
- The treatment approach differs between fever and hyperthermia, with antipyretics being effective for fever but ineffective for hyperthermia, which requires external cooling 8
Key Clinical Findings on Fever and Hyperthermia
Drug‑Induced Fever
- In drug hypersensitivity reactions, fever typically appears after a mean latency of 21 days (median 8 days) from drug initiation and resolves within 1–3 days (occasionally up to 7 days) after the offending agent is stopped【9】.
Genetic Hyperthermic Syndromes
- Malignant hyperthermia is caused by a genetically determined dysregulation of skeletal‑muscle calcium handling, leading to intense muscle contraction and rapid heat production; it is most often triggered by succinylcholine or halogenated anesthetic agents【9】.
Atypical Fever Presentation in Infections
- Certain patient groups—including the elderly, individuals with open wounds or burns, patients receiving extracorporeal therapies or continuous renal replacement, and those on anti‑inflammatory medications—may remain euthermic or hypothermic despite having a serious infection【10】.
Prognostic Implications of Absent Fever
- The absence of fever in patients with infection is associated with poorer clinical outcomes【11】.
Population Trends in Baseline Body Temperature
- Over the past 157 years, the average human baseline body temperature has declined by approximately 0.03 °C per birth decade, a shift that influences contemporary fever definitions【11】.